Norway
Norway’s institutes span across all EATRIS platforms: Biomarkers, ATMP & Biological, Imaging & Tracing, Small Molecules and Vaccines. Norwegian nodes have been active in the flagship EATRIS-Plus project and the H2020 project European Joint Program on Rare Diseases. Additionally, The University of Oslo has joined a COST action consortium building and Platform dementia consortium with other EATIS institutions, amongst many other EATRIS activities.